Chiasma, Inc. (CHMA - Free Report) was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 26.1% in the past one-month time frame.
The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Chiasma. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Chiasma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Chiasma, Inc. Price
Investors interested in the Medical - Biomedical and Genetics industry may consider Acorda Therapeutics, Inc. (ACOR - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CHMA going up? Or down? Predict to see what others think:Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>